Cargando…

Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients

BACKGROUND: Severe acute pancreatitis (SAP) is a common disease in the intensive care unit (ICU) accompanied by high mortality, the purpose of this study was to build a prediction model for the 30 days mortality of SAP. METHODS: We retrospectively reviewed 149 patients with SAP after admission in 48...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Li, Qing, Ma, Liang, Cai, Zhenzhen, Zhou, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364556/
https://www.ncbi.nlm.nih.gov/pubmed/37477658
http://dx.doi.org/10.1080/07853890.2023.2236648
_version_ 1785076868907532288
author Chen, Ying
Li, Qing
Ma, Liang
Cai, Zhenzhen
Zhou, Jun
author_facet Chen, Ying
Li, Qing
Ma, Liang
Cai, Zhenzhen
Zhou, Jun
author_sort Chen, Ying
collection PubMed
description BACKGROUND: Severe acute pancreatitis (SAP) is a common disease in the intensive care unit (ICU) accompanied by high mortality, the purpose of this study was to build a prediction model for the 30 days mortality of SAP. METHODS: We retrospectively reviewed 149 patients with SAP after admission in 48 h to the ICU of the First Affiliated Hospital of Nanjing Medical University between January 2015 and December 2019. Clinical variables including gender, age, blood routine, and biochemical indicators were collected. On the basis of these variables, stepwise regression analysis was carried out to establish the model. A bootstrapping technique was applied for internal validation. RESULTS: Age, aspartate aminotransferase (AST), alkaline phosphatase (ALP), triglycerides (TG), and creatinine (CREA) were differences between survivors and nonsurvivors groups (all p < 0.1). Multivariate analysis suggested that age, AST, ALP, TG, and CREA were independent variables. Then, a model was established. The area-under-the curve (AUC) of the model was 0.875 (95% confidence interval (CI): 0.811–0.924). After internal validation, the C-index was 0.859 (95% CI: 0.786–0.932). CONCLUSION: Our study has built a refined model with easily acquired biochemical parameters to predict 30 days mortality of SAP admitted to ICU. This model will require external and prospective validation prior to translate into clinical management.
format Online
Article
Text
id pubmed-10364556
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-103645562023-07-25 Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients Chen, Ying Li, Qing Ma, Liang Cai, Zhenzhen Zhou, Jun Ann Med Gastroenterology BACKGROUND: Severe acute pancreatitis (SAP) is a common disease in the intensive care unit (ICU) accompanied by high mortality, the purpose of this study was to build a prediction model for the 30 days mortality of SAP. METHODS: We retrospectively reviewed 149 patients with SAP after admission in 48 h to the ICU of the First Affiliated Hospital of Nanjing Medical University between January 2015 and December 2019. Clinical variables including gender, age, blood routine, and biochemical indicators were collected. On the basis of these variables, stepwise regression analysis was carried out to establish the model. A bootstrapping technique was applied for internal validation. RESULTS: Age, aspartate aminotransferase (AST), alkaline phosphatase (ALP), triglycerides (TG), and creatinine (CREA) were differences between survivors and nonsurvivors groups (all p < 0.1). Multivariate analysis suggested that age, AST, ALP, TG, and CREA were independent variables. Then, a model was established. The area-under-the curve (AUC) of the model was 0.875 (95% confidence interval (CI): 0.811–0.924). After internal validation, the C-index was 0.859 (95% CI: 0.786–0.932). CONCLUSION: Our study has built a refined model with easily acquired biochemical parameters to predict 30 days mortality of SAP admitted to ICU. This model will require external and prospective validation prior to translate into clinical management. Taylor & Francis 2023-07-21 /pmc/articles/PMC10364556/ /pubmed/37477658 http://dx.doi.org/10.1080/07853890.2023.2236648 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Gastroenterology
Chen, Ying
Li, Qing
Ma, Liang
Cai, Zhenzhen
Zhou, Jun
Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
title Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
title_full Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
title_fullStr Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
title_full_unstemmed Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
title_short Development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
title_sort development and internal validation of a practical model to predict 30 days mortality of severe acute pancreatitis patients
topic Gastroenterology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364556/
https://www.ncbi.nlm.nih.gov/pubmed/37477658
http://dx.doi.org/10.1080/07853890.2023.2236648
work_keys_str_mv AT chenying developmentandinternalvalidationofapracticalmodeltopredict30daysmortalityofsevereacutepancreatitispatients
AT liqing developmentandinternalvalidationofapracticalmodeltopredict30daysmortalityofsevereacutepancreatitispatients
AT maliang developmentandinternalvalidationofapracticalmodeltopredict30daysmortalityofsevereacutepancreatitispatients
AT caizhenzhen developmentandinternalvalidationofapracticalmodeltopredict30daysmortalityofsevereacutepancreatitispatients
AT zhoujun developmentandinternalvalidationofapracticalmodeltopredict30daysmortalityofsevereacutepancreatitispatients